HIGHLIGHTS
- who: Filip Rob et al. from the Editor:, University of Minnesota have published the research work: Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study, in the Journal: PLOS ONE of 29/Oct/2022
- what: In this preliminary study the authors provide a unique overview of the longitudinal monitoring of fecal and skin microbial profiles as well as various serum biomarkers and humoral and 1 / 24 and changes in serum biomarkers and microbiota composition in patients with IBD Zuzana Jiraskova Zakostelska . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.